John L Lubniewski Insider Trading $HTGM HTG MOLECULAR DIAGNOSTICS, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John L Lubniewski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John L Lubniewski. John L Lubniewski is Chief Business Officer in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and President & CEO in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and President & COO in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and SVP, Chief Business Officer in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM).
John L Lubniewski in HTG MOLECULAR DIAGNOSTICS, INC
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of John L Lubniewski: President & CEO, President & COO, SVP, Chief Business Officer, Chief Business Officer
Holdings: 10,442 shares
Current Value: $19,213
Latest Transaction: Apr 02 2021
$HTGM Market Capitalization: $12.65M
$HTGM Previous Close: $1.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John L Lubniewski in HTG MOLECULAR DIAGNOSTICS, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 5.47 | 62 | 339 | 10,442 | 10.5 K to 10.4 K (-0.59 %) |
| Jan 04 2021 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 4.79 | 62 | 297 | 10,504 | 10.6 K to 10.5 K (-0.59 %) |
| Dec 16 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 4.87 | 66 | 321 | 10,566 | 10.5 K to 10.6 K (+0.63 %) |
| Oct 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.33 | 921 | 304 | 157,534 | 158.5 K to 157.5 K (-0.58 %) |
| Aug 24 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.48 | 1,200,000 | 576,000 | 1,200,000 | |
| Jun 15 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 0.55 | 1,000 | 553 | 159,376 | 158.4 K to 159.4 K (+0.63 %) |
| Apr 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.33 | 1,086 | 358 | 158,376 | 159.5 K to 158.4 K (-0.68 %) |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.66 | 537,500 | 354,750 | 537,500 | |
| Jan 27 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.66 | 537,500 | 354,750 | 537,500 | |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.70 | 921 | 645 | 159,462 | 160.4 K to 159.5 K (-0.57 %) |
| Jan 02 2020 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.70 | 921 | 645 | 159,462 | 160.4 K to 159.5 K (-0.57 %) |
| Dec 12 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 0.57 | 701 | 396 | 160,383 | 159.7 K to 160.4 K (+0.44 %) |
| Oct 02 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 0.66 | 921 | 608 | 159,682 | 160.6 K to 159.7 K (-0.57 %) |
| Aug 19 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 0.95 | 112,500 | 106,875 | 112,500 | |
| Jul 03 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 1.66 | 921 | 1,529 | 160,603 | 161.5 K to 160.6 K (-0.57 %) |
| Jun 13 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Grant | A | 1.57 | 761 | 1,197 | 161,524 | 160.8 K to 161.5 K (+0.47 %) |
| May 24 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Option Exercise | A | 2.22 | 300,000 | 666,000 | 300,000 | |
| Apr 01 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & CEO | Payment of Exercise | F | 2.50 | 909 | 2,273 | 160,763 | 161.7 K to 160.8 K (-0.56 %) |
| Jan 02 2019 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Payment of Exercise | F | 2.54 | 921 | 2,339 | 161,672 | 162.6 K to 161.7 K (-0.57 %) |
| Dec 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Buy | J | 1.57 | 735 | 1,156 | 162,593 | 161.9 K to 162.6 K (+0.45 %) |
| Oct 02 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Payment of Exercise | F | 4.52 | 921 | 4,163 | 161,858 | 162.8 K to 161.9 K (-0.57 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Option Exercise | A | 3.40 | 100,000 | 340,000 | 100,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Grant | A | 0.00 | 50,000 | 0 | 162,779 | 112.8 K to 162.8 K (+44.33 %) |
| Jun 14 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | President & COO | Buy | J | 1.57 | 788 | 1,239 | 112,779 | 112 K to 112.8 K (+0.70 %) |
| Jan 31 2018 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | SVP, Chief Business ... | Grant | A | 0.00 | 63,483 | 0 | 111,991 | 48.5 K to 112 K (+130.87 %) |
| Dec 15 2017 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 1.61 | 818 | 1,314 | 48,508 | 47.7 K to 48.5 K (+1.72 %) |
| Jul 17 2017 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 1.79 | 901 | 1,616 | 47,690 | 46.8 K to 47.7 K (+1.93 %) |
| Dec 14 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 1.83 | 834 | 1,524 | 46,789 | 46 K to 46.8 K (+1.81 %) |
| Aug 30 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Grant | A | 0.00 | 20,000 | 0 | 45,955 | 26 K to 46 K (+77.06 %) |
| Jun 14 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 2.54 | 928 | 2,359 | 25,955 | 25 K to 26 K (+3.71 %) |
| Apr 05 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.92 | 87 | 254 | 25,027 | 25.1 K to 25 K (-0.35 %) |
| Apr 05 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.89 | 709 | 2,048 | 25,114 | 25.8 K to 25.1 K (-2.75 %) |
| Mar 14 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.19 | 113 | 247 | 25,823 | 25.9 K to 25.8 K (-0.44 %) |
| Mar 14 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.36 | 5,264 | 12,399 | 25,936 | 31.2 K to 25.9 K (-16.87 %) |
| Mar 14 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.49 | 1,512 | 3,765 | 31,200 | 32.7 K to 31.2 K (-4.62 %) |
| Mar 09 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Sell | S | 2.69 | 4,067 | 10,927 | 32,712 | 36.8 K to 32.7 K (-11.06 %) |
| Mar 08 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Grant | A | 0.00 | 25,708 | 0 | 36,779 | 11.1 K to 36.8 K (+232.21 %) |
| Feb 17 2016 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Option Exercise | A | 2.36 | 35,000 | 82,600 | 35,000 | |
| Aug 31 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Grant | A | 0.00 | 2,500 | 0 | 11,071 | 8.6 K to 11.1 K (+29.17 %) |
| Aug 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | P | 7.50 | 14 | 105 | 8,571 | 8.6 K to 8.6 K (+0.16 %) |
| Aug 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | P | 7.67 | 4,986 | 38,243 | 8,557 | 3.6 K to 8.6 K (+139.62 %) |
| May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Option Exercise | C | 0.00 | 76,138 | 0 | 0 | |
| May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Option Exercise | C | 0.00 | 228,414 | 0 | 0 | |
| May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 0.00 | 737 | 0 | 3,571 | 2.8 K to 3.6 K (+26.01 %) |
| May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | C | 0.00 | 708 | 0 | 2,834 | 2.1 K to 2.8 K (+33.30 %) |
| May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | C | 0.00 | 2,126 | 0 | 2,126 | 0 to 2.1 K |
Page: 1